Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins

Blood

Volumn 115, Issue 6, 2010, Pages 1303-1312

  Marathe, Dhananjay D ^a   Buffone Jr , Alexander ^a   Chandrasekaran, E V ^b   Xue, Jun ^b   Locke, Robert D ^b   Nasirikenari, Mehrab ^b   Lau, Joseph T Y ^b   Matta, Khushi L ^b   Neelamegham, Sriram ^a  

^a the State University of New York   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ACETAMIDO 1,3,6 TRI O ACETYL 2,4 DIDEOXY 4 FLUORO D GALACTOPYRANOSE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; L SELECTIN; MONOSACCHARIDE; N ACETYLLACTOSAMINE SYNTHASE; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG; 2 ACETAMIDO 1,3,6 TRI O ACETYL 4 DEOXY 4 FLUOROGLUCOPYRANOSE; 2-ACETAMIDO-1,3,6-TRI-O-ACETYL-4-DEOXY-4-FLUOROGLUCOPYRANOSE; DRUG DERIVATIVE; HECA PROTEIN, HUMAN; MEMBRANE PROTEIN; N ACETYLGLUCOSAMINE; P SELECTIN LIGAND PROTEIN; P-SELECTIN LIGAND PROTEIN; POLYSACCHARIDE; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL CYCLE; CELL STRAIN HL 60; CELL SURFACE; CONTROLLED STUDY; CYTOMETRY; GLYCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; ACETYLATION; ANIMAL; BLOOD GROUP LEWIS SYSTEM; BONE MARROW CELL; C57BL MOUSE; CELL MOTION; CHEMISTRY; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; LEUKOCYTE; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PROTEIN BINDING; WESTERN BLOTTING;

ACETYLATION; ACETYLGLUCOSAMINE; ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELL ADHESION; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GLYCOSYLATION; HL-60 CELLS; HUMANS; LEUKOCYTES; LEWIS BLOOD-GROUP SYSTEM; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; PERITONITIS; POLYSACCHARIDES; PROTEIN BINDING;

EID: 77949514632     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-07-231480     Document Type: Article

References (50)

1. Neelamegham S. Transport features, reaction kinetics and receptor biomechanics controlling selectin and integrin mediated cell adhesion. Cell Commun Adhes. 2004;11(1):35-50. (Pubitemid 39069729)
2. Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev. 1999;79(1):181-213. (Pubitemid 29056952)
3. Ley K. The role of selectins in inflammation and disease. Trends Mol Med. 2003;9(6):263-268.
4. Aeed PA, Geng JG, Asa D, Raycroft L, Ma L, Elhammer AP. Characterization of the O-linked oligosaccharide structures on P-selectin glycoprotein ligand-1 (PSGL-1). Glycoconj J. 1998; 15(10):975-985. (Pubitemid 29129198)
5. Wilkins PP, McEver RP, Cummings RD. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. J Biol Chem. 1996; 271(31):18732-18742. (Pubitemid 26322741)
6. Simanek EE, McGarvey GJ, Jablonowski JA, Wong CH. Selectin-carbohydrate interactions: from natural ligands to designed mimics. Chem Rev. 1998;98(2):833-862.
7. He XY, Xu Z, Melrose J, et al. Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectin. J Immunol. 1998;160(2):1029-1035. (Pubitemid 28049350)
8. Bhushan M, Bleiker TO, Ballsdon AE, et al. Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial. Br J Dermatol. 2002; 146(5):824-831. (Pubitemid 34539192)
9. Co MS, Landolfi NF, Nagy JO, et al. Properties and pharmacokinetics of two humanized antibodies specific for L-selectin. Immunotechnology. 1999;4(3):253-266.
10. Sako D, Comess KM, Barone KM, Camphausen RT, Cumming DA, Shaw GD.Asulfated peptide segment at the amino terminus of PSGL-1 is critical for Pselectin binding. Cell. 1995;83(2):323-331.
11. Woodside DG, Vanderslice P. Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease. BioDrugs. 2008;22(2):85-100.
12. Kuan SF, Byrd JC, Basbaum C, Kim YS. Inhibition of mucin glycosylation by aryl-N-acetylalpha-galactosaminides in human colon cancer cells. J Biol Chem. 1989;264(32):19271-19277.
13. Sarkar AK, Fritz TA, Taylor WH, Esko JD. Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1->4GlcNAc beta-O-naphthalenemethanol. Proc Natl Acad Sci U S A. 1995;92(8):3323-3327.
14. Sarkar AK, Rostand KS, Jain RK, Matta KL, Esko JD. Fucosylation of disaccharide precursors of sialyl LewisX inhibit selectin-mediated cell adhesion. J Biol Chem. 1997;272(41):25608-25616.
15. Brown JR, Fuster MM, Whisenant T, Esko JD. Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys. J Biol Chem. 2003;278(26): 23352-23359. (Pubitemid 36830150)
16. Fuster MM, Brown JR, Wang L, Esko JD. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res. 2003; 63(11):2775-2781. (Pubitemid 36667148)
17. Takayama S, Chung SJ, Igarashi Y, et al. Selective inhibition of beta-1,4- and alpha-1,3-galactosyltransferases: donor sugar-nucleotide based approach. Bioorg Med Chem. 1999;7(2): 401-409. (Pubitemid 29117106)
18. Schworer R, Schmidt RR. Efficient sialyltransferase inhibitors based on glycosides of N-acetylglucosamine. J Am Chem Soc. 2002; 124(8):1632-1637. (Pubitemid 34173886)
19. Ahsen O, Voigtmann U, Klotz M, et al.Aminiaturized high-throughput screening assay for fucosyltransferase VII. Anal Biochem. 2008;372(1):96-105.
20. Woynarowska B, Dimitroff CJ, Sharma M, Matta KL, Bernacki RJ. Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoroglucosamine analogue. Glycoconj J. 1996;13(4): 663-674. (Pubitemid 26271285)
21. Yarema KJ, Goon S, Bertozzi CR. Metabolic selection of glycosylation defects in human cells. Nat Biotechnol. 2001;19(6):553-558. (Pubitemid 32521187)
22. Sharma M, Bernacki RJ, Paul B, Korytnyk W. Fluorinated carbohydrates as potential plasma membrane modifiers: synthesis of 4- and 6-fluoro derivatives of 2-acetamido-2-deoxy-D-hexopyranoses. Carbohydr Res. 1990;198(2):205-221. (Pubitemid 23068359)
23. Paul B, Bernacki RJ, Korytnyk W. Synthesis and biological activity of some 1-N-substituted 2-acetamido-2-deoxy-beta-D-glycopyranosylamine derivatives and related analogs. Carbohydr Res. 1980;80(1):99-115.
24. Thomas RL, Abbas SA, Matta KL. Synthesis of uridine 5′-(2- acetamido-2,4-dideoxy-4-fluoroalpha-D-galactopyranosyl) diphosphate and uridine 5′-(2-acetamido-2,6-dideoxy-6-fluoro-alpha-D-glucopyranosyl) diphosphate. Carbohydr Res. 1988;184:77-85.
25. Berkin A, Szarek WA, Kisilevsky R. Synthesis of 4-deoxy-4-fluoro analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-galactose and their effects on cellular glycosaminoglycan biosynthesis. Carbohydr Res. 2000; 326(4):250-263. (Pubitemid 30386914)
26. Goon S, Bertozzi CR. Metabolic substrate engineering as a tool for glycobiology. J Carbohydrate Chem. 2002;21(7):943-977.
27. Woynarowska B, Skrincosky DM, Haag A, Sharma M, Matta K, Bernacki RJ. Inhibition of lectin-mediated ovarian tumor cell adhesion by sugar analogs. J Biol Chem. 1994;269(36): 22797-22803. (Pubitemid 24273393)
28. Dimitroff CJ, Bernacki RJ, Sackstein R. Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin. Blood. 2003;101(2):602-610. (Pubitemid 36077583)
29. Descheny L, Gainers ME, Walcheck B, Dimitroff CJ. Ameliorating skin-homing receptors on malignant T cells with a fluorosugar analog of Nacetylglucosamine: P-selectin ligand is a more sensitive target than E-selectin ligand. J Invest Dermatol. 2006;126(9):2065-2073. (Pubitemid 44244851)
30. Dimitroff CJ, Kupper TS, Sackstein R. Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. J Clin Invest. 2003;112(7):1008-1018. (Pubitemid 38056316)
31. Gainers ME, Descheny L, Barthel SR, Liu L, Wurbel MA, Dimitroff CJ. Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis. J Immunol. 2007;179(12):8509-8518.
32. Varki A, Cummings R, Esko J, Freeze H, Hart G, Marth J. Essentials of Glycobiology. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1999.
33. Zhang Y, Neelamegham S. Estimating the efficiency of cell capture and arrest in flow chambers: study of neutrophil binding via E-selectin and ICAM-1. Biophys J. 2002;83(4):1934-1952.
34. Beauharnois ME, Lindquist KC, Marathe D, et al. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin. Biochemistry. 2005;44(27):9507-9519. (Pubitemid 40962049)
35. Marathe DD, Chandrasekaran EV, Lau JT, Matta KL, Neelamegham S. Systems-level studies of glycosyltransferase gene expression and enzyme activity that are associated with the selectin binding function of human leukocytes. FASEB J. 2008;22(12):4154-4167.
36. Nasirikenari M, Segal BH, Ostberg JR, Urbasic A, Lau JT. Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I. Blood. 2006;108(10):3397-3405.
37. Ohmori K, Fukui F, Kiso M, et al. Identification of cutaneous lymphocyte-associated antigen as sialyl 6-sulfo Lewis X, a selectin ligand expressed on a subset of skin-homing helper memory T cells. Blood. 2006;107(8):3197-3204.
38. Beauharnois ME, Neelamegham S, Matta KL. Quantitative measurement of selectin-ligand interactions: assays to identify a sweet pill in a library of carbohydrates. Methods Mol Biol. 2006; 347:343-358.
39. Boxio R, Bossenmeyer-Pourie C, Steinckwich N, Dournon C, Nusse O. Mouse bone marrow contains large numbers of functionally competent neutrophils. J Leukoc Biol. 2004;75(4):604-611. (Pubitemid 38405651)
40. Borges E, Eytner R, Moll T, et al. The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum. Blood. 1997;90(5):1934-1942. (Pubitemid 27377304)
41. Bosse R, Vestweber D. Only simultaneous blocking of the L- and P-selectin completely inhibits neutrophil migration into mouse peritoneum. Eur J Immunol. 1994;24(12):3019-3024.
42. Varki A. Selectin ligands: will the real ones please stand up? J Clin Invest. 1997;99(2):158-162. (Pubitemid 27053457)
43. Jung U, Norman KE, Scharffetter-Kochanek K, Beaudet AL, Ley K. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J Clin Invest. 1998;102(8):1526-1533. (Pubitemid 28492219)
44. Maemura K, Fukuda M. Poly-N-acetyllactosaminyl O-glycans attached to leukosialin: the presence of sialyl Le(x) structures in O-glycans. J Biol Chem. 1992;267(34):24379-24386.
45. Mitoma J, Bao X, Petryanik B, et al. Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment. Nat Immunol. 2007; 8(4):409-418. (Pubitemid 46745416)
46. Fu J, Gerhardt H, McDaniel JM, et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest. 2008;118(11):3725-3737.
47. Sperandio M, Thatte A, Foy D, Ellies LG, Marth JD, Ley K. Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferasedeficient mice. Blood. 2001;97(12):3812-3819.
48. Brockhausen I. Biosynthesis of the O-glycan Chains of Mucins and Mucin Type Glycoproteins. Vol 3. New York, NY: Wiley-VCH; 2000.
49. Brockhausen I, Kuhns W, Schachter H, Matta KL, Sutherland DR, Baker MA. Biosynthesis of Oglycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells. Cancer Res. 1991;51(4):1257-1263.
50. Nigro J, Wang A, Mukhopadhyay D, et al. Regulation of heparan sulfate and chondroitin sulfate glycosaminoglycan biosynthesis by 4-fluoroglucosamine in murine airway smooth muscle cells. J Biol Chem. 2009;284(25):16832-16839.